Entasis Anticipates First FDA Approval Of Pathogen-Specific Antibacterial

 
• By Joseph Haas
  
Antibiotic-resistant-bacteria
Entasis tested its combo antibacterial against colistin
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D